SCHEMBL8026439

SCHEMBL8026439

N#Cc1ccc(Cc2nc3cc(NS(=O)(=O)c4ccccc4)ccc3n2CC(=O)O)cc1

nearest known ligand 0.62

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
F2 P00734 6/20 0.62
BRPF1 P55201 3/20 0.47
SMARCA2 P51531 1/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
ALDH1A1 P00352 1/20 0.46
PKM P14618 1/20 0.46
PAX8 Q06710 2/20 0.45
POLB P06746 1/20 0.45
LMNA P02545 1/20 0.44
BRD4 O60885 1/20 0.43
BRD1 O95696 1/20 0.43
BRD9 Q9H8M2 1/20 0.43
BRPF3 Q9ULD4 1/20 0.43
USP2 O75604 1/20 0.42
HPGD P15428 1/20 0.42
HSD17B10 Q99714 1/20 0.42
AR P10275 1/20 0.42
SERPINE1 P05121 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8026550 0.90 F2 (0.73) F2BRPF1SMARCA2SMN1; SMN2ALDH1A1
SCHEMBL8029744 0.89 F2 (0.60) F2BRPF1SMARCA2SMN1; SMN2ALDH1A1
SCHEMBL8028568 0.89 F2 (0.61) F2BRPF1SMARCA2SMN1; SMN2ALDH1A1
SCHEMBL8017541 0.87 F2 (0.72) F2BRPF1SMARCA2SMN1; SMN2ALDH1A1
SCHEMBL8026521 0.85 F2 (0.56) F2BRPF1SMARCA2SMN1; SMN2ALDH1A1
SCHEMBL8032284 0.85 F2 (0.60) F2BRPF1SMARCA2SMN1; SMN2ALDH1A1
SCHEMBL8027058 0.85 F2 (0.70) F2BRPF1SMN1; SMN2ALDH1A1PKM
SCHEMBL8029890 0.85 F2 (0.82) F2SMN1; SMN2ALDH1A1PKMPAX8
SCHEMBL8028279 0.84 F2 (0.59) F2BRPF1SMARCA2SMN1; SMN2ALDH1A1
SCHEMBL8143300 0.83 F2 (0.58) F2BRPF1SMARCA2SMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1060166-A1 FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS Boehringer Ingelheim Pharma KG (DE) 2000-12-20 EP disclosed
US-6114532-A ANTICOAGULANT BOEHRINGER INGELHEIM PHARMA KG (DE) 2000-09-05 US disclosed
WO-1999040072-A1 FIVE-MEMBERED, BENZO-CONDENSED HETEROCYCLES USED AS ANTITHROMBOTIC AGENTS BOEHRINGER INGELHEIM PHARMA KG (DE) 1999-08-12 WO disclosed